12/09/2025 13:05
Guardant Health and Policlinico Gemelli Launch In-House Liquid Biopsy Testing Service in Italy

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the successful launch of FPG 360, an in-house liquid biopsy testing service at the Fondazione Policlinico Universitario Agostino Gemelli IRCCS (Policlinico Gemelli) in Rome, Italy. This partnership is the latest in a series of public-private partnerships Guardant Health has formed with top-tier European academic and research hospitals that embed its groundbreaking technology with existing care pathways to ...

11/06/2025 16:11
NJ Bio Bridges the Translation Research Gap with the Asset Purchase and Integration of L2P® Services

NJ Bio, Inc., a premier contract research and clinical manufacturing service provider in Princeton, New Jersey has announced the asset purchase and full integration of the research services of L2P Research Labs® (“Lab to Pharmacy”), further expanding its service portfolio, and bridging the translational research gap. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251106703527/en/NJ Bio, Inc. now offers translational research services...

12/09/2025 13:33
Gulf Oil Selects DataXstream’s OMS+ Portal to Power LATAM Digital Transformation

DataXstream LLC, an SAP® Endorsed App partner developing innovative solutions for SAP sales and distribution, today announced that Gulf Oil, a globally recognized lubricant company with operations in more than 25 countries, has selected OMS+ Portal to modernize and unify the company’s customer-facing sales platform across Latin America. The project is part of a broader initiative to streamline operations, enhance scalability and deliver a seamless buying experience that is fully integrated with...

11/12/2025 23:00
Indero Announces Breakthrough Method for Early-Phase Evaluation of Topical Drugs Using Quantitative Gene Expression

Indero is proud to announce the successful completion of an internally funded study that introduces a novel approach to evaluating topical new chemical entities (NCE) in early-phase clinical research. This innovative method leverages quantitative gene expression analysis to assess drug efficacy rapidly and cost effectively. Dr. Robert Bissonnette, Executive Chairman and Founder of Indero, who initiated and led the study, shared his excitement about the results: “Our goal was to rethink how ...

12/09/2025 14:00
Indero Named Best Employer by Mercer

Indero, a global CRO specializing in dermatology and rheumatology, has been honored by Mercer, recognizing its excellence as a Best Employer. Indero is proud of its long-term commitment to building a workplace culture defined by trust, fairness, and meaningful employee experiences and believes this distinction reflects its positive impact in 2025. The Best Employers in Canada – Powered by Mercer certification program recognizes organizations that consistently deliver a positive and engaging emp...

12/09/2025 14:00
Skyhigh Security Enhances DSPM Capabilities to Support DPDPA Compliance and Strengthen Data Protection Across Asia Pacific

Skyhigh Security, the leader in data-first Secure Service Edge, today announced the launch of its actionable, intelligent and risk-focused data visibility and compliance dashboard as part of Skyhigh DSPM’s Data Explorer. In April 2025, Data Security Posture Management (DSPM) was officially integrated into Skyhigh Security’s SSE framework, to provide visibility into where data resides within cloud environments. Taking things a step further, the new dashboard delivers unified, real-time visibilit...